Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Cash | 1.25 | 21.61 | 0.74 | 0.15 |
Cash Equivalents | 0.27 | 0.24 | 0.70 | 0.66 |
Cashand Short Term Investments | 1.52 | 21.86 | 1.44 | 0.81 |
Accounts Receivable- Trade Net | 920.60 | 172.37 | 64.00 | 23.68 |
Total Receivables Net | 1,810.98 | 1,124.38 | 138.11 | 33.85 |
Total Inventory | 133.23 | 7.32 | 83.87 | 3.11 |
Other Current Assets Total | 2.11 | 0.58 | 0.16 | 0.55 |
Total Current Assets | 1,947.85 | 1,154.14 | 223.57 | 38.32 |
Property/ Plant/ Equipment Total- Net | 0.05 | 0.08 | 0.09 | 0.07 |
Other Long Term Assets Total | 0.03 | 0.01 | 0.00 | 0.00 |
Total Assets | 1,947.92 | 1,154.22 | 223.76 | 38.53 |
Accounts Payable | 712.29 | 84.22 | 124.56 | 23.77 |
Notes Payable/ Short Term Debt | 57.70 | 0.00 | 0.00 | 0.00 |
Other Currentliabilities Total | 1,134.98 | 1,059.64 | 94.26 | 0.40 |
Total Current Liabilities | 1,904.97 | 1,143.86 | 218.82 | 24.17 |
Long Term Debt | 0.00 | 0.00 | 0.00 | 10.50 |
Total Long Term Debt | 0.00 | 0.00 | 0.00 | 10.50 |
Total Debt | 57.70 | 0.00 | 0.00 | 10.50 |
Deferred Income Tax | 0.00 | 0.00 | 0.00 | 0.00 |
Total Liabilities | 1,904.97 | 1,143.86 | 218.82 | 34.68 |
Common Stock Total | 10.08 | 3.60 | 3.60 | 3.60 |
Other Equity Total | 32.88 | 6.76 | 1.34 | 0.26 |
Total Equity | 42.96 | 10.36 | 4.94 | 3.86 |
Total Liabilities Shareholders' Equity | 1,947.92 | 1,154.22 | 223.76 | 38.53 |
Total Common Shares Outstanding | 10.08 | 10.08 | 10.08 | 10.08 |
Tangible Book Valueper Share Common Eq | 4.26 | 1.03 | 0.48 | 0.37 |
Intangibles Net | - | - | 0.10 | 0.14 |
Remedium Lifecare Dividend Remedium Lifecare Bonus Remedium Lifecare News Remedium Lifecare AGM Remedium Lifecare Rights Remedium Lifecare Splits Remedium Lifecare Board Meetings Remedium Lifecare Key Metrics Remedium Lifecare Shareholdings Remedium Lifecare Profit Loss Remedium Lifecare Cashflow Remedium Lifecare Q1 Results Remedium Lifecare Q2 Results Remedium Lifecare Q3 Results Remedium Lifecare Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks